{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 79, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 688750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 77, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 652500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 56, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 69, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 64, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 571375, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 70, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.49, "open": 1.33, "dayLow": 1.18, "dayHigh": 1.33, "regularMarketPreviousClose": 1.49, "regularMarketOpen": 1.33, "regularMarketDayLow": 1.18, "regularMarketDayHigh": 1.33, "payoutRatio": 0.0, "beta": 1.179, "forwardPE": 6.3157897, "volume": 651360, "regularMarketVolume": 651360, "averageVolume": 292453, "averageVolume10days": 1122940, "averageDailyVolume10Day": 1122940, "bid": 1.15, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 10312116, "fiftyTwoWeekLow": 1.18, "fiftyTwoWeekHigh": 26.25, "fiftyDayAverage": 2.0864, "twoHundredDayAverage": 9.12365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12927990, "profitMargins": 0.0, "floatShares": 7839101, "sharesOutstanding": 8593430, "sharesShort": 517586, "sharesShortPriorMonth": 540139, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0602, "heldPercentInsiders": 0.05736, "heldPercentInstitutions": 0.07966, "shortRatio": 2.93, "shortPercentOfFloat": 0.0639, "impliedSharesOutstanding": 8593430, "bookValue": 8.465, "priceToBook": 0.14176019, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -40723212, "trailingEps": -5.82, "forwardEps": 0.19, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.303, "52WeekChange": -0.9502591, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.2, "targetHighPrice": 100.0, "targetLowPrice": 8.0, "targetMeanPrice": 39.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 1100079, "totalCashPerShare": 0.128, "ebitda": -42693260, "totalDebt": 204569, "quickRatio": 0.025, "currentRatio": 0.409, "debtToEquity": 0.297, "returnOnAssets": -0.24469, "returnOnEquity": -0.5248, "freeCashflow": 9927698, "operatingCashflow": -26791916, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Citius Pharmaceuticals, Inc.", "corporateActions": [], "preMarketTime": 1743593188, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Citius Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketPrice": 1.2, "regularMarketChange": -0.28999996, "regularMarketDayRange": "1.18 - 1.33", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 292453, "fiftyTwoWeekLowChange": 0.0200001, "fiftyTwoWeekLowChangePercent": 0.016949238, "fiftyTwoWeekRange": "1.18 - 26.25", "fiftyTwoWeekHighChange": -25.05, "fiftyTwoWeekHighChangePercent": -0.9542857, "fiftyTwoWeekChangePercent": -95.02591, "dividendDate": 1496966400, "earningsTimestamp": 1739568603, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.82, "epsForward": 0.19, "epsCurrentYear": 1.35, "priceEpsCurrentYear": 0.8888889, "fiftyDayAverageChange": -0.8864, "fiftyDayAverageChangePercent": -0.42484662, "twoHundredDayAverageChange": -7.92365, "twoHundredDayAverageChangePercent": -0.8684737, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": -19.463085, "regularMarketPrice": 1.2, "marketState": "PRE", "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null}